Monitoring the development of non-nucleoside reverse transcriptase inhibitor-associated resistant HIV-1 using an electrochemiluminescence-based reverse transcriptase polymerase assay

Analytical Biochemistry

Volumn 374, Issue 1, 2008, Pages 121-132

  Munshi, Vandna ^a   Lu, Meiqing ^a   Felock, Peter ^a   Barnard, Richard J O ^a   Hazuda, Daria J ^a   Miller, Michael D ^a   Lai, Ming Tain ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

ECL based assay; HIV 1; NNRTI; Resistance mutation; RT polymerase assay

Indexed keywords

BIOMOLECULES; CELL CULTURE; CLONE CELLS; POLYMERS;

DOUBLE-STRAND DNAS; ELECTROCHEMILUMINESCENCE; HIV-1; NNRTI; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; REPLICATION PROCESS; REVERSE TRANSCRIPTASES; THERAPEUTIC STRATEGY;

VIRUSES;

DELAVIRDINE; EFAVIRENZ; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS MUTATION; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38349147989     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.10.004     Document Type: Article

References (30)

1. Gotte M., Li X., and Wainberg M.A. HIV-1 reverse transcription: A brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch. Biochem. Biophys. 365 (1999) 199-210
2. Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., and Miller M.D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287 (2000) 646-650
3. Castro H.C., Loureiro N.I., Pujol-Luz M., Souza A.M., Albuquerque M.G., Santos D.O., Cabral L.M., Frugulhetti I.C., and Rodrigues C.R. HIV-1 reverse transcriptase: A therapeutical target in the spotlight. Curr. Med. Chem. 13 (2006) 313-324
4. Moore J.P., and Stevenson M. New targets for inhibitors of HIV-1 replication. Nat. Rev. Mol. Cell Biol. 1 (2000) 40-49
5. Hopkins A.L., Ren J., Esnouf R.M., Willcox B.E., Jones E.Y., Ross C., Miyasaka T., Walker R.T., Tanaka H., Stammers D.K., and Stuart D.I. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J. Med. Chem. 39 (1996) 1589-1600
6. Balzarini J. Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Curr. Top. Med. Chem. 4 (2004) 921-944
7. Tarby C.M. Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors. Curr. Top. Med. Chem. 4 (2004) 1045-1057
8. Boone L.R. Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors. Curr. Opin. Invest. Drugs 7 (2006) 128-135
9. De Clercq E. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antiviral Res. 38 (1998) 153-179
10. Janssen P.A., Lewi P.J., Arnold E., Daeyaert F., de Jonge M., Heeres J., Koymans L., Vinkers M., Guillemont J., Pasquier E., Kukla M., Ludovici D., Andries K., de Bethune M.P., Pauwels R., Das K., Clark Jr. A.D., Frenkel Y.V., Hughes S.H., Medaer B., De Knaep F., Bohets H., De Clerck F., Lampo A., Williams P., and Stoffels P. In search of a novel anti-HIV drug: Multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J. Med. Chem. 48 (2005) 1901-1909
11. Bosworth N., and Towers P. Scintillation proximity assay. Nature 341 (1989) 167-168
12. Chang A., and Dusing S. Practical assay issues with the PERT/PBRT assay: A highly sensitive reverse transcriptase assay. Dev. Biol. (Basel) 123 (2006) 91-97
13. Eberle J., and Seibl R. A new method for measuring reverse transcriptase activity by ELISA. J. Virol. Methods 40 (1992) 347-356
14. Suzuki K., Craddock B.P., Kano T., and Steigbigel R.T. Chemiluminescent enzyme-linked immunoassay for reverse transcriptase, illustrated by detection of HIV reverse transcriptase. Anal. Biochem. 210 (1993) 277-281
15. Suzuki K., Craddock B.P., Kano T., and Steigbigel R.T. Colorimetric reverse transcriptase assay for HIV-1. J. Virol. Methods 41 (1993) 21-28
16. Mlinaric A., Kac J., and Pohleven F. Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors. Acta Pharm. 55 (2005) 69-79
17. Ekstrand D.H., Awad R.J., Kallander C.F., and Gronowitz J.S. A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive product detection, with special reference to human immunodeficiency virus isolation. Biotechnol. Appl. Biochem. 23 (1996) 95-105
18. Malmsten A., Ekstrand D.H., Akerblom L., Gronowitz J.S., Kallander C.F., Bendinelli M., and Matteucci D. A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity. J. Virol. Methods 75 (1998) 9-20
19. Shaw-Reid C.A., Munshi V., Graham P., Wolfe A., Witmer M., Danzeisen R., Olsen D.B., Carroll S.S., Embrey M., Wai J.S., Miller M.D., Cole J.L., and Hazuda D.J. Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid. J. Biol. Chem. 278 (2003) 2777-2780
20. Loya S., Bakhanashvili M., Kashman Y., and Hizi A. Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2, Arch. Biochem. Biophys. 316 (1995) 789-796
21. Goldman M.E., Nunberg J.H., O'Brien J.A., Quintero J.C., Schleif W.A., Freund K.F., Gaul S.L., Saari W.S., Wai J.S., and Hoffman J.M. Pyridinone derivatives: Specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc. Natl. Acad. Sci. USA 88 (1991) 6863-6867
22. Olsen D.B., Carroll S.S., Culberson J.C., Shafer J.A., and Kuo L.C. Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor. Nucleic Acids Res. 22 (1994) 1437-1443
23. Das K., Lewi P.J., Hughes S.H., and Arnold E. Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog. Biophys. Mol. Biol. 88 (2005) 209-231
24. Hsiou Y., Ding J., Das K., Clark Jr. A.D., Boyer P.L., Lewi P., Janssen P.A., Kleim J.P., Rosner M., Hughes S.H., and Arnold E. The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance. J. Mol. Biol. 309 (2001) 437-445
25. Marozsan A.J., Fraundorf E., Abraha A., Baird H., Moore D., Troyer R., Nankja I., and Arts E.J. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. J. Virol. 78 (2004) 11130-11141
26. Yang H., Leland J.K., Yost D., and Massey R.J. Electrochemiluminescence: A new diagnostic and research tool-ECL detection technology promises scientists new "yardsticks" for quantification. Biotechnology (N.Y.) 12 (1994) 193-194
27. Pietrak B.L., Crouthamel M.C., Tugusheva K., Lineberger J.E., Xu M., DiMuzio J.M., Steele T., Espeseth A.S., Stachel S.J., Coburn C.A., Graham S.L., Vacca J.P., Shi X.P., Simon A.J., Hazuda D.J., and Lai M.T. Biochemical and cell-based assays for characterization of BACE-1 inhibitors. Anal. Biochem. 342 (2005) 144-151
28. Lai M.T., Crouthamel M.C., DiMuzio J., Pietrak B.L., Donoviel D.B., Bernstein A., Gardell S.J., Li Y.M., and Hazuda D. A presenilin-independent aspartyl protease prefers the γ-42 site cleavage. J. Neurochem. 96 (2006) 118-125
29. Li Y.M., Lai M.T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M.K., Shi X.P., Yin K.C., Shafer J.A., and Gardell S.J. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state. Proc. Natl. Acad. Sci. USA 97 (2000) 6138-6143
30. Pyra H., Boni J., and Schupbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. USA 91 (1994) 1544-1548